Evidence map›Paper›PMID 37649584›Full record

ArticlePNAS nexus2023

Disproportionate impact of COVID-19 severity and mortality on hospitalized American Indian/Alaska Native patients.

Ivy Hurwitz, Alexandra V Yingling, Teah Amirkabirian, Amber Castillo, Jehanzaeb J Khan, Alexandra Do, Dominic K Lundquist, October Barnes, Christophe G Lambert, Annabeth Fieck and 13 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in PNAS nexus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 3 institutions in 3 countries.

Ivy HurwitzCenter for Global Health, Department of Internal Medicine, University of New Mexico Health Sciences Center, MSC10 5550, 1 University of New Mexico, Albuquerque, NM 87131-0001, USA.ORCID https://orcid.org/0000-0003-1566-1111
Alexandra V YinglingCenter for Global Health, Department of Internal Medicine, University of New Mexico Health Sciences Center, MSC10 5550, 1 University of New Mexico, Albuquerque, NM 87131-0001, USA.
Teah AmirkabirianCenter for Global Health, Department of Internal Medicine, University of New Mexico Health Sciences Center, MSC10 5550, 1 University of New Mexico, Albuquerque, NM 87131-0001, USA.
Amber CastilloCenter for Global Health, Department of Internal Medicine, University of New Mexico Health Sciences Center, MSC10 5550, 1 University of New Mexico, Albuquerque, NM 87131-0001, USA.ORCID https://orcid.org/0000-0002-9037-9215
Jehanzaeb J KhanDivision of Hospital Medicine, Department of Internal Medicine, University of New Mexico Health Sciences Center, MSC10 5550, 1 University of New Mexico, Albuquerque, NM 87131-0001, USA.
Alexandra DoSchool of Medicine, University of New Mexico, MSC08 4720, 1 University of New Mexico, Albuquerque, NM 87131-0001, USA.ORCID https://orcid.org/0009-0009-7365-7306
Dominic K LundquistSchool of Medicine, University of New Mexico, MSC08 4720, 1 University of New Mexico, Albuquerque, NM 87131-0001, USA.
October BarnesCenter for Global Health, Department of Internal Medicine, University of New Mexico Health Sciences Center, MSC10 5550, 1 University of New Mexico, Albuquerque, NM 87131-0001, USA.
Christophe G LambertCenter for Global Health, Department of Internal Medicine, University of New Mexico Health Sciences Center, MSC10 5550, 1 University of New Mexico, Albuquerque, NM 87131-0001, USA.ORCID https://orcid.org/0000-0003-1994-2893
Annabeth FieckCenter for Global Health, Department of Internal Medicine, University of New Mexico Health Sciences Center, MSC10 5550, 1 University of New Mexico, Albuquerque, NM 87131-0001, USA.
Gregory MertzCenter for Global Health, Department of Internal Medicine, University of New Mexico Health Sciences Center, MSC10 5550, 1 University of New Mexico, Albuquerque, NM 87131-0001, USA.
Clinton OnyangoCenter for Global Health, Department of Internal Medicine, University of New Mexico Health Sciences Center, MSC10 5550, 1 University of New Mexico, Albuquerque, NM 87131-0001, USA.
Samuel B AnyonaCenter for Global Health, Department of Internal Medicine, University of New Mexico Health Sciences Center, MSC10 5550, 1 University of New Mexico, Albuquerque, NM 87131-0001, USA.ORCID https://orcid.org/0000-0001-5813-4018
J Pedro TeixeiraDivision of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, University of New Mexico Health Sciences Center, MSC10 5550, 1 University of New Mexico, Albuquerque, NM 87131-0001, USA.ORCID https://orcid.org/0000-0002-2466-9644
Michelle HarkinsDivision of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, University of New Mexico Health Sciences Center, MSC10 5550, 1 University of New Mexico, Albuquerque, NM 87131-0001, USA.ORCID https://orcid.org/0000-0002-9679-2553
Mark UnruhDivision of Nephrology, Department of Internal Medicine, University of New Mexico Health Sciences Center, MSC10 5550, 1 University of New Mexico, Albuquerque, NM 87131-0001, USA.ORCID https://orcid.org/0000-0001-7103-656X
Qiuying ChengCenter for Global Health, Department of Internal Medicine, University of New Mexico Health Sciences Center, MSC10 5550, 1 University of New Mexico, Albuquerque, NM 87131-0001, USA.ORCID https://orcid.org/0000-0002-1343-1171
Shuguang LengCenter for Global Health, Department of Internal Medicine, University of New Mexico Health Sciences Center, MSC10 5550, 1 University of New Mexico, Albuquerque, NM 87131-0001, USA.ORCID https://orcid.org/0000-0002-9860-8158
Philip SeidenbergDepartment of Emergency Medicine, University of New Mexico Health Sciences Center, MSC11 6025, 1 University of New Mexico, Albuquerque, NM 87131-0001, USA.
Anthony WorshamDivision of Hospital Medicine, Department of Internal Medicine, University of New Mexico Health Sciences Center, MSC10 5550, 1 University of New Mexico, Albuquerque, NM 87131-0001, USA.ORCID https://orcid.org/0000-0003-4367-4577
Jens O LangsjoenDivision of Hospital Medicine, Department of Internal Medicine, University of New Mexico Health Sciences Center, MSC10 5550, 1 University of New Mexico, Albuquerque, NM 87131-0001, USA.
Kristan A SchneiderDepartment of Applied Computer- and Biosciences, University of Applied Sciences Mittweida, Technikumplatz 17, 09648 Mittweida, Germany.ORCID https://orcid.org/0000-0003-4138-1180
Douglas J PerkinsCenter for Global Health, Department of Internal Medicine, University of New Mexico Health Sciences Center, MSC10 5550, 1 University of New Mexico, Albuquerque, NM 87131-0001, USA.ORCID https://orcid.org/0000-0001-9390-6255
University of New Mexico · USUniversity of New Mexico Hospital · USHochschule Mittweida · DE

Funding

Temporal Transcriptomics in Hospitalized COVID-19 Patients from Disparately Impacted Ancestral Groups for Therapeutic DiscoveryR01AI160662 · NIAID · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI PERKINS, DOUGLAS JAY · 2021 to 2023
$2.3M
NIAID NIH HHS R01 AI160662
6 · The paper itself

Abstract

Epidemiological data across the United States of America illustrate health disparities in COVID-19 infection, hospitalization, and mortality by race/ethnicity. However, limited information is available from prospective observational studies in hospitalized patients, particularly for American Indian or Alaska Native (AI/AN) populations. Here, we present risk factors associated with severe COVID-19 and mortality in patients (4/2020-12/2021, n = 475) at the University of New Mexico Hospital. Data were collected on patient demographics, infection duration, laboratory measures, comorbidities, treatment(s), major clinical events, and in-hospital mortality. Severe disease was defined by COVID-related intensive care unit requirements and/or death. The cohort was stratified by self-reported race/ethnicity: AI/AN (30.7%), Hispanic (47.0%), non-Hispanic White (NHW, 18.5%), and Other (4.0%, not included in statistical comparisons). Despite similar timing of infection and comparable comorbidities, admission characteristics for AI/AN patients included younger age (

Indexed as

COVID-19hospitalizationrace/ethnicity

Identifiers

PMID37649584
PMCPMC10465079
OpenAlexW4386247198

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.